Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas

International Journal of Oncology

Volumn 32, Issue 5, 2008, Pages 1111-1117

  Sorbe, Bengt ^a   Johansson, Birgit ^a  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Prognosis; Prophylactic irradiation; Surgery; Uterine sarcomas

Indexed keywords

ADULT; AGED; ARTICLE; BLOODY DIARRHEA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOSARCOMA; CONTROLLED STUDY; DIARRHEA; ENDOMETRIUM SARCOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEMATURIA; HUMAN; HYSTERECTOMY; INTESTINE FISTULA; INTESTINE OBSTRUCTION; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; SECONDARY PREVENTION; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; UTERUS SARCOMA; VAGINAL HYSTERECTOMY; ADJUVANT THERAPY; DISEASE FREE SURVIVAL; ENDOMETRIUM TUMOR; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; METASTASIS; MITOSIS INDEX; MORTALITY; PATHOLOGY; PELVIS; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; UTERUS CANCER;

BRACHYTHERAPY; CARCINOSARCOMA; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; KAPLAN-MEIERS ESTIMATE; LEIOMYOSARCOMA; LYMPHATIC METASTASIS; MITOTIC INDEX; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PELVIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; TIME FACTORS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 45849107274     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.5.1111     Document Type: Article

References (43)

1. Tavassoli FA and Devilee P (eds): Pathology and genetics: Tumours of the breast and female genital organs. WHO classification of tumours series, IARC Press, Lyon, 2003.
2. Disaia PJ and Creasman WT: Sarcoma of the uterus. In: Clinical Gynecologic Oncology. Disaia PJ and Creasman WT (eds). Mosby, St. Louis, pp 173-184, 2002.
3. Harlow BL, Weiss NS and Lofton S: The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76: 399-402, 1986.
4. Pautier P, Genestie C, Rey A et al: Analysis of clinico-pathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88: 1425-1431,2000.
5. Livi L, Paiar F, Shah N, Blake P, Villanucci A, Amunni G, Barca R, Judson I, Lodge N, Meldolesi E, Simontacchi G, Piperno G, Galardi A, Scoccianti S, Biti GP and Harmer C: Uterine sarcoma: Twenty-seven years of experience. Int J Radiat Oncol Biol Phys 57: 1366-1373, 2003.
6. Rose PG, Piver MS, Tsukada Y and Lau T: Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer 63: 935-938, 1989.
7. Sagae S, Yamashita K, Ishioka S, Nishioka Y, Terasawa K, Mori M, Yamashiro K, Kanemoto T and Kudo R: Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 67: 33-9, 2004.
8. Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A, Bazzurini L, Arisio R, Romagnolo C and Cristofani R: Uterine leiomyosarcomas: Analysis of Treatment Failures and Survival. Gynecol Oncol 62: 25-32, 1996.
9. Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currei JL, et al: Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71: 1702-1709, 1993.
10. Chi DS, Mychalczak B, Saigo PE, Recigno J and Brown CL: The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol 65: 493-498, 1997.
11. Benoit L, Arnould L, Cheynel N, Goui S, Collin F, Fraisse J and Cuisenier J: The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 31: 434-442, 2005.
12. Peters WA, Fleming WP and Morley GW: Prognostic features of sarcomas and mixed tumors of the endometrium. Obstet Gynecol 63: 550-556, 1984.
13. Arrastia CD, Fruchter RG, Clark M, et al: Uterine carcinosarcomas: Incidence and trends in management and survival. Gynecol Oncol 65: 158-63, 1997.
14. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao S-Y and Miller A: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 9: 1-9, 1990.
15. Villena-Heinsen C, Diesing C, Fischer D, Griesinger D, Maas G, Diedrich N and Friedrich M: Carcinosarcomas - a retrospective analysis of 21 patients. Anticancer Res 26: 4817-4823, 2006.
16. Pautier P, Rey A, Haie-Meder C, Kerbrat P, Dutel JL, Gesta P, Bryard F, Morice P, Duvillard P and Lhomme C: Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone. Int J Gynecol Cancer 14: 1112-1117, 2004.
17. Odunsi K, Moneke V, Tammela J, Ghamande S, Seago P, Driscoll D, Marchetti D, Baker T and Lele S: Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. Int J Gynecol Cancer 14: 659-664, 2004.
18. Nordal RR, Kristensen GB, Stenwig AE, Nesland JM, Pettersen EO and Tropé CG: An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol 67: 316-321, 1997.
19. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S and Mayerhofer K: Evaluating prognostic parameters in women with uterine leiomyosarcomas. A clinicopathologic study. J Reprod Med 48: 95-100, 2003.
20. Morice P, Rodrigues A, Pautier P, Rey A, Camatte S, Atallah D, Pomel C, Lhomme C, Haie-Meder C, Duvillard P and Castaigne D: Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure. Gyn Obstet Fert 31: 147-150, 2003.
21. Dinh TA, Oliva EA, Fuller AF Jr, Lee H and Goodman A: The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol 92: 648-652, 2004.
22. Gard GB, Mulvany NJ and Quinn MA: Management of uterine leiomyosarcoma in Australia. Aust NZ J Obstet Gynaecol 39: 93-98, 1999.
23. Kelly KL and Craighead PS: Characteristics and management of uterine sarcoma patients treated at the Tom Baker Cancer Centre. Int J Gynecol Cancer 15: 132-139, 2005.
24. Brooks SE, Zhan M, Cote T and Baquet CR: Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 93: 204-208, 2004.
25. Soumarova R, Horova H, Seneklova Z, Ruzickova J, Horova I, Budikova M, Slampa P and Kalabova R: Treatment of uterine sarcoma. A survey of 49 patients. Archiv Gynecol Obstet 266: 92-95, 2002.
26. Riddle PJ, Echeta CB, Manek S, Lavery BA, Charnock FM, Mackenzie I and Ganesan TS: Retrospective study of management of uterine sarcomas at Oxford 1990-1998: role of adjuvant treatment. Clin Oncol 14: 54-61,2002.
27. Le T: Adjuvant pelvic radiotherapy for uterine carcinosarcomas in a high risk population. Eur J Surg Oncol 27: 282-285, 2001.
28. Ferrer F, Sabater S, Farrus B, Guedea F, Rovirosa F, Anglada L, Delannes M, Marin S, DuBois JB and Daly-Schveitzer N: Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Group Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys 44: 47-52, 1999.
29. Knocke TH, Kucera H, Dorfler D, Pokrajac B and Potter R: Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 83: 1972-1979, 1998.
30. Etiz D, Garipaaolu M, Etiz EE, Kose FM, Kayikciolu F, Haberal A, Citak L and Cakmak A: Results of postoperative radiotherapy in the treatment of 29 uterine sarcoma patients. Tumori 89: 183-188, 2003.
31. Chi DS, Mychalczak B, Saigo PE, Rescigno J and Brown CL: The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcomas. Gynecol Oncol 65: 493-498, 1997.
32. Numa F, Umayahara K, Ogata H, Nawata S, Sakaguchi Y, Emoto T, Kawasaki K, Hirakawa H, Sase M, Oga A and Kato H: De novo uterine sarcoma with good response to neo-adjuvant chemotherapy. Int J Gynecol Cancer 13: 364-367, 2003.
33. Kushner DM, Webster KD, Belinson JL, Rybicki LA, Kennedy AW and Markman M: Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma. Gynecol Oncol 78: 221-227, 2000.
34. Toyoshima M, Akahira J, Matsunaga G, Niikura H, Ito K, Yaegashi N and Tase T: Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcomas of the uterus. Gynecol Oncol 94: 774-778, 2004.
35. Wu TI, Chang TC, Hsueh S, Hsu KH, Chou HH, Huang HJ and Lai CH: Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol 100: 166-172, 2006.
36. Soh LT, Chew SH and Ang L: Uterine leiomyosarcoma - a Singapore experience. Aust NZ J Obstet Gynaecol 39: 246-248, 1999.
37. Menczer J, Levy T, Piura B, Chetrit A, Altaras M, Meirovitz M, Glezerman M, Fishman A: A comparison between different postoperative modalities of uterine carcinosarcomas. Gynecol Oncol 97: 166-170, 2005.
38. Kanjeekal S, Chambers A, Fung FMK and Verma S: Systematic therapy for advanced uterine sarcoma: a systematic review of the literature. Gynecol Oncol 97: 624-637, 2005.
39. McCluggage WG: Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12: 687-690, 2002.
40. Diesing D, Cordes T, Finas D, Loning M, Mayer K, Diedrich K and Friedrich M: Endometrial stromal sarcomas - a retrospective analysis of 11 patients. Anticancer Res 26: 655-661, 2006.
41. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S and Mayerhofer K: Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res 23: 729-732, 2003.
42. Livasy CA, Reading FC, Moore DT, Boggess JF and Lininger RA: EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcomas. Gynecol Oncol 100: 101-106, 2006.
43. Raspollini MR, Susini T, Amunni G, Paglierani M, Castiglione F, Garbini F, Carriero C, Scarselli G and Taddei GL: Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment? Int J Gynecol Cancer 16: 416-422, 2006.